Back to News
Market Impact: 0.2
IBA et Telix renforcent leur collaboration avec un accord de distribution de la technologie QIS® d’ARTMS
Source: GlobeNewswire
Product LaunchesHealthcare & BiotechTechnology & Innovation
IBA will offer its QUANTM irradiation system to cyclotron users worldwide to accelerate local production of radiometals for theranostic applications. The rollout expands access to technology supporting nuclear-medicine diagnostics and targeted treatments, though no financial terms or expected revenue impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
IBAB0.55
More News
- Nvidia Faces Questions Over China AI Chip Smuggling Cases
- Broadcom to lend Anthropic up to $42 billion to lease its chips, filing says
- $8.2B acquisition validates AI-picked chip stock: +20% since June
- Markets slip on dollar pressure, but this IT stock is up 10% today
- One of our most recent defensive buys cleared a hurdle and its stock jumped
- AI’s biggest players promise to police themselves at the White House
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Eli Lilly Q4 2025 Earnings: Revenue Surges 43% as Mounjaro and Zepbound Dominate the GLP-1 Market
- Investment Research Software Costs: A 2026 Budget Framework